Ercan CİĞERLİ, Halil SAYGILI, Gülengil NADİRGİL, Murat Ekrem BİLGİN

Pelvik enflamatuvar hastalıkta klinik ve laboratuvar bulgularımız

Objective: The aim of this study was to compare patients with pelvic inflammatory disease with abscess and those without abscess in relation to clinical and laboratory findings and risk factors in an attempt to highlight the predictors of tuboovarian abscess in pelvic inflammatory disease. Materials and methods: This retrospectively designed study was carried out in Istanbul University, Istanbul Faculty of Medicine, Department of Obstetrics and Gynecology. Fifty-two patients with pelvic inflammatory disease who were hospitalized in our clinic between the years of 1999-2002 were included in this study. Sixteen patients with pelvic inflammatory disease with tuboovarian abscess and 36 patients with pelvic inflammatory disease without any abscess were assessed retrospectively. Both groups were compared with regard to the risk factors, clinical and laboratory parameters such white blood cell counts, age, parity, mucopurulent cervical discharge, curettage and fever, using independent samples t-test and chi square tests. Results: There was no statistically significant difference between the ages of the patients in both groups. The mean of white blood cells and the percentage of patients with multiparity, with cervical discharge, and with fever were statistically significantly higher in the group of patients with pelvic inflammatory disease with abscess than in those without abscess. Conclusion: The findings in this study suggested that multiparity, leucocytosis, mucopurulent discharge and fever could predict tuboovarian abscess formation in pelvic inflammatory disease.

Our clinical and laboratory findings in pelvic inflammatory disease

PDF

___

1) Corsi PJ, Johnson SC, Gonik B, Hendrix SL, McNeeley SG Jr, Diamond MP. Transvaginal ultrasound-guided aspiration of pelvic abscess. Infect Dis Obstetric Gynecol 1999;7:216- 221.
2) Eschenbach DA. Epidemiology and diagnosis of acute pelvic inflammatory disease. Obstetric Gynecol 1980;55(5 suppl):142-153.
3) Eschenbach DA, Holmes KK. Acute PID: current concepts of pathogenesis, etiology and management. Clin Obstet Gynecol 1975;18:35-56.
4) Genc M, Mardh PA. Cost-effective analysis of screening and treatment for chlamydia trachomatis infections in asymptomatic women. Ann Intern Med 1996;124:1-7
5) Ginsburg DS, Stern JL, Hamod KA, Genadry R, Spence MR. Tubo-ovarian abscess: a retrospective review. Am J Obstet Gynecol 1980; 138:1055–1058.
6) Hager WD, Eschenbach DA, Spece MR, Sweet RL. Criteria for diagnosis and grading of salpingitis. Obst Gynecol 1983;61:113-114.
7) Igra V. Pelvic Inflammatory disease in adolescents. AIDS Patient Care STDS 1998;12:109-124.
8) Ivey JB. The adolescent with pelvic inflammatory disease; assessment and management. Nurse Pract 1997;22:78,81- 4,87-8,92-93.
9) Lawson MA, Blythe MJ. Pelvic inflammatory disease in adolescents . Pediatr Clin North Am 1999;46:767-782.
10) McNeeley SG, Hendrix SL, Mazzoni MM, Kmak DC, Ransom SB. Medically sound , cost-effective treatment for pelvic inflammatory disease and tuboovarian abscess. Am J Obstet Gynecol 1998;178:1272-1278.
11) Peipert JF, Broadman L, Hogan JW, Sung J, Mayer KH. Laboratory evulation of acute upper genital tract infection. Obstet Gynecol 1996; 87:730-736.
12) Sholes D, Stergachis A, Hiedrich FE, Andrilla H, Holmes KK, Stamm WE. Prevention of pelvic inflammatory disease by screening for cervical chlamydia infection. N Engl J Med 1996;334:1362-1366.
13) Soper DE, Brockwell NJ, Dalton HP. Microbial etiology of urban emergency department acute salpingitis: treatment with ofloxacin. Am J Obstet Gynecol 1992;167:653-660.
14) Soper DE, Brockwell NJ, Dalton HP, Johnson D. Observations concerning the microbial etiology of acute salpingitis. Am J Obstet Gynecol 1994;170:1008-1017.
15) Wasserheit JN, Bell TA, Kiviat NB, Wolner-Hanssen P, Zabriskie V, Kirby BD, Prince EC, Holmes KK, Stamm WE, Eschenbach DA. Microbial causes of proven pelvic inflammatory disease and efficacy of clindamycin and tobramycin. Ann Intern Med 1986;104:187-193.